Filing Details
- Accession Number:
- 0000937556-17-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-04 17:18:02
- Reporting Period:
- 2017-03-31
- Filing Date:
- 2017-04-04
- Accepted Time:
- 2017-04-04 17:18:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363597 | Mark Raad De | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-31 | 6,000 | $37.84 | 14,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-31 | 6,000 | $93.13 | 8,660 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-31 | 12,000 | $31.01 | 20,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-31 | 12,000 | $93.14 | 8,660 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-04-03 | 12,000 | $21.97 | 20,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-03 | 12,000 | $93.31 | 8,660 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-04-04 | 18,000 | $28.03 | 26,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-04 | 18,000 | $93.34 | 8,660 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-31 | 6,000 | $37.84 | 6,000 | $37.84 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-31 | 12,000 | $31.01 | 12,000 | $31.01 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-04-03 | 12,000 | $21.97 | 12,000 | $21.97 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-04-04 | 18,000 | $28.03 | 18,000 | $28.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,000 | 2017-02-28 | 2026-02-28 | No | 4 | M | Direct |
| 18,000 | 2016-03-20 | 2025-03-20 | No | 4 | M | Direct |
| 12,000 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
| 12,000 | 2015-02-18 | 2024-02-18 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 17, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.77 per share to a high of $93.48 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $93.50 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $94.67 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.94 per share to a high of $93.83 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on February 29, 2016 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on March 20, 2015 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on February 18, 2014 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
